Susan D. DeVore - 27 Mar 2026 Form 4 Insider Report for Solventum Corp (SOLV)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
30 Mar 2026, 19:43:43 UTC
Prior SEC filing
21 Aug 2025
Next SEC filing
01 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Megan Bombick, attorney-in-fact for Susan D. DeVore

Key filing fact

Susan D. DeVore filed Form 4 for Solventum Corp (SOLV) on 30 Mar 2026.

Key facts

  • This page summarizes Susan D. DeVore's Form 4 filing for Solventum Corp (SOLV).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 30 Mar 2026, 19:43.

Change

  • Previous filing in this sequence was filed on 21 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001587697 Primary reporting owner

DeVore Susan D.

Relationship
Director
Address
1750 YANKEE DOODLE ROAD, EAGAN
Signature
/s/Megan Bombick, attorney-in-fact for Susan D. DeVore
Signature date
30 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SOLV transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,980
Change %
+56%
Price
$0.000000*
Shares after
5,544
Date
27 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SOLV transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-1,980
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,980
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.

Footnote F2

The RSUs are fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .